Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric A Ross

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
The Journal of Urology|April 7, 2020
Sporadic Angiomyolipomas Growth Kinetics While on Everolimus: Results of a Phase II TrialDaniel M Geynisman, Brian T Kadow, Brian M Shuch, et al.
Clinical Lung Cancer|July 14, 2023
Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never SmokedJ Nicholas Bodor, Jyoti D Patel, Heather A Wakelee, et al.
The Journal of Urology|June 24, 2020
Reply by AuthorsDaniel M Geynisman, Brian T Kadow, Brian M Shuch, et al.
BMC Medicine|March 3, 2026
Risks of non-breast, non-ovarian cancers for BRCA1 and BRCA2 pathogenic variant carriers: a prospective cohort studyRuotong Yang, Robert J MacInnis, Roger L Milne, et al.
Breast Cancer Research : BCR|March 30, 2019
Genomic signature of parity in the breast of premenopausal womenJulia Santucci-Pereira, Anne Zeleniuch-Jacquotte, Yelena Afanasyeva, et al.
Cancer|January 22, 2013
A Web-based communication aid for patients with cancer: the CONNECT StudyNeal J Meropol, Brian L Egleston, Joanne S Buzaglo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2014
Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicityElizabeth R Plimack, Jean H Hoffman-Censits, Rosalia Viterbo, et al.
Journal of Proteome Research|April 21, 2007
Searchable high-resolution 2D gel proteome of the human colon cryptBhavinkumar B Patel, Xin-Ming Li, Maketa P Dixon, et al.
European Urology|August 5, 2015
Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder CancerElizabeth R Plimack, Roland L Dunbrack, Timothy A Brennan, et al.
Oncotarget|September 30, 2016
Haploinsufficiency in tumor predisposition syndromes: altered genomic transcription in morphologically normal cells heterozygous for VHL or TSC mutationSuraj Peri, Elena Caretti, Rossella Tricarico, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
The Journal of Urology|April 7, 2020
Sporadic Angiomyolipomas Growth Kinetics While on Everolimus: Results of a Phase II TrialDaniel M Geynisman, Brian T Kadow, Brian M Shuch, et al.
Clinical Lung Cancer|July 14, 2023
Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never SmokedJ Nicholas Bodor, Jyoti D Patel, Heather A Wakelee, et al.
The Journal of Urology|June 24, 2020
Reply by AuthorsDaniel M Geynisman, Brian T Kadow, Brian M Shuch, et al.
BMC Medicine|March 3, 2026
Risks of non-breast, non-ovarian cancers for BRCA1 and BRCA2 pathogenic variant carriers: a prospective cohort studyRuotong Yang, Robert J MacInnis, Roger L Milne, et al.
Breast Cancer Research : BCR|March 30, 2019
Genomic signature of parity in the breast of premenopausal womenJulia Santucci-Pereira, Anne Zeleniuch-Jacquotte, Yelena Afanasyeva, et al.
Cancer|January 22, 2013
A Web-based communication aid for patients with cancer: the CONNECT StudyNeal J Meropol, Brian L Egleston, Joanne S Buzaglo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2014
Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicityElizabeth R Plimack, Jean H Hoffman-Censits, Rosalia Viterbo, et al.
Journal of Proteome Research|April 21, 2007
Searchable high-resolution 2D gel proteome of the human colon cryptBhavinkumar B Patel, Xin-Ming Li, Maketa P Dixon, et al.
European Urology|August 5, 2015
Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder CancerElizabeth R Plimack, Roland L Dunbrack, Timothy A Brennan, et al.
Oncotarget|September 30, 2016
Haploinsufficiency in tumor predisposition syndromes: altered genomic transcription in morphologically normal cells heterozygous for VHL or TSC mutationSuraj Peri, Elena Caretti, Rossella Tricarico, et al.
Pageof 10